Patent · US Active

High frequency application of botulinum toxin therapy

US8557255B2 · kind B2 · utility

10Cited by

13References

14Claims

0Family size

Assignee

Merz Pharma GmbH & Co. KGaA · DE

Inventors

Matthias Marx · Fürstenfeldbruck, DE
Susanne Grafe · Frankfurt am Main, DE
Reiner Benecke · Neu Thulendorf, DE
Dirk Dressler · Hamburg, DE

Key dates

Filing date	Jun 29, 2007
Grant date	Oct 15, 2013
Priority date	—
Expiry date	Jun 29, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to methods for treating diseases and disorders by administering a composition containing the neurotoxic component of a Clostridium botulinum toxin complex, wherein the composition is devoid of any other protein of the Clostridium botulinum toxin complex and wherein the composition is administered at short intervals and/or in high doses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.